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Abstract: Background and objectives: Attention-deficit/hyperactivity disorder (ADHD) is one of the
most common psychiatric disorders in children and adolescents. Mind–body therapies (MBTs) seem
to be effective for improving health in different populations; however, whether a positive effect occurs
in children and adolescents with ADHD is still controversial. The main aim of this systematic review
was to analyse the interventions based on MBT aimed to improve the main ADHD symptoms in
children and adolescents. Materials and Methods: A systematic review was conducted following the
preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines to identify
MBT studies on children and adolescents (4–18 years) with a clinical diagnosis of ADHD. Study quality
was evaluated by the NIH quality tool (U.S. National Institute of Health). Results: There were positive
results in eleven out of twelve included studies regarding the effect of the MBT interventions on ADHD
symptoms. With respect to ADHD symptoms, we observed differences across studies. In relation to
the studies’ quality, eleven studies were rated “poor” and one was rated as “fair”. Conclusions: MBTs,
such as yoga or mindfulness, could be positive strategies to mitigate ADHD symptoms in children and
adolescents. However, further research with high-quality designs, with randomization, greater sample
sizes, and more intensive supervised practice programs are needed.
Keywords: mind–body therapies; relaxation therapy; attention-deficit/hyperactivity disorder symptom;
children; adolescents
1. Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common behavioral disorder that affects
from 1% to 20% of the children worldwide [1,2], but overall, the pooled prevalence of ADHD is around
5% [3]. ADHD is characterized by pervasive and impairing symptoms of inattention, hyperactivity,
and impulsivity according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition
(DSM-5) [4]. The etiology of ADHD is multifaceted and multidimensional, linking genetic and
environmental factors [5]. ADHD has been characterized as a major public health problem due to
the broad range of negative effects in diagnosed people and the serious expenses for families and
society. According to the American Psychiatric Association in the DSM-V, to be considered ADHD
a child must have symptoms before the age of 12 years, for at least six months, and affecting two
domains of life [6]. The prevalence of the three subtypes of ADHD are: inattentive (20–30% of
diagnosed population), hyperactive-impulsive (less than 15%), and combined subtype (50–75%) [7].
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Eleven percent of children ages 4 to 17 in the United States (6.4 million children) have been diagnosed
with attention-deficit hyperactivity disorder, according to a survey by the Centers for Disease Control
and Prevention [8]. Boys are diagnosed with ADHD three times more frequently than girls. Therefore,
evidence corroborates the solid influence of genetic factors on the expression of symptoms; however,
psychosocial, environmental, and cultural factors also play an important role in this disorder [9].
To date, ADHD symptoms have been treated with different therapies. A previous systematic
review study suggested aerobic exercise had a moderate to large influence on core symptoms of ADHD
in children and adolescents [10]. This study indicated that short-term aerobic exercise attenuates
ADHD symptoms such as attention, hyperactivity, impulsivity, anxiety, executive functions, and social
disorders in diagnosed children. In a study with a sample of 7000 youths with mental health concerns,
such as ADHD, depression, and anxiety, complementary alternative medicine therapies had an
important role, where mind–body therapies (MBTs) were the most used [11]. Accordingly, MBTs such
as yoga, mindfulness, or meditation offered a wide range of positive effects on psychosocial, emotional,
and neurobiological functioning in several populations [6]. These non-invasive techniques are based
on positive thoughts and emotions to improve emotional and behavioral health. Such techniques
consist of deep breathing, meditation, mindfulness, guided imagery, progressive relaxation, and yoga
exercises [12]. It has been shown that the practice of these therapies can change brain activation
patterns, contribute to improve mood and reduce anxiety, stress, and pain, in addition to developing
attention control and inhibitory skills [13]. The neurophysiological mechanisms implicated respond to
activation to dopaminergic and noradrenergic systems. The successful pharmacological treatments
used from preschooler ages are mainly composed of psychostimulant drugs that increase dopaminergic
action [14], however, the MBTs could active the liberation of this hormone without the typical adverse
side effect of these chemical medications [15]. In light of these benefits, a few intervention studies
have investigated the function of MBTs in controlling ADHD symptoms in young people. However,
the potential benefits of MBTs on symptoms of ADHD in youths are still controversial. Thus, the main
aim of this systematic review (SR) was to analyse the interventions based on MBT aimed to improve
the main ADHD symptoms in children and adolescents.
2. Materials and Methods
We followed the recommendations of preferred reporting items for systematic reviews and
meta-analyses (PRISMA) statement [16]. The PRISMA checklist of this SR can be found in
Supplementary Table S1.
2.1. Study Eligibility Criteria
Intervention studies focused on MBTs carried out to improve the main symptoms of ADHD
in children and adolescents (4–18 years old) were included in the current systematic review. First,
the current study included studies enrolling children and adolescents with a clinical diagnosis of
ADHD. All ADHD subtypes (i.e., combined type, predominantly inattentive, and predominantly
hyperactive/impulsive) were considered as valid studies, following a previous search protocol [10].
Studies including patients with comorbid conditions (such as anxiety, depression, epilepsy, or other
medical conditions) were not eligible. Second, the present review considered studies evaluating
only MBT-based interventions such as, yoga, meditation, mindfulness, relaxation, or zen therapies or
programs. Finally, the main outcomes of the studies included in this SR were the principal ADHD
symptoms, such as inattention, hyperactivity, or impulsivity, and related skills, which are attenuated
with ADHD diagnostics (e.g., accuracy rate, reaction time, etc.).
Other secondary outcomes related to ADHD, such as anxiety, shyness, social problems,
perfectionism, self-reported emotion dysregulation, depressive symptoms, and parent’s emotional
regulation and feelings, were included in the description of the intervention studies.
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2.2. Search Methods for Identification of Studies
A PICOS approach was used for framing the research question and the evidence search [17].
Participants: Child* OR adolescent* OR young* OR youth. Interventions: Yoga OR yogic OR meditation
OR Tai Chi OR mindfulness OR mindful OR mindfulness-based OR mind-body OR relaxation OR zen.
Comparisons: Not applicable. Outcomes: Medical condition terms (ADHD OR attention deficit OR
attention-deficit OR hyperkinetic syndrome OR hyperkinetic disorder). Study design: intervention OR program
OR therapy OR training OR school-based intervention. Additional filters: All database, builder terms:
Title/abstract for PubMed, Topic for Web of Science, and abstract for PsycINFO and EBSCOHost,
Publication years from 2000 to 2018.
Thus, relevant randomized trials included in systematic reviews were reviewed. A search
was performed in the following databases with no language/date/type of document restrictions:
Web of Knowledge databases (Web of Science (science citation index expanded), PubMed, PsycINFO,
and EBSCOHost, in order to identify additional relevant intervention studies published beyond
these reviews [18]. The specific electronic search for each database and terms included are shown in
Supplementary File S1.
Additionally, references from the included studies were hand-searched to discover any potential
study not detected with the electronic search.
2.3. Screening and Data Extraction
2.3.1. Screening
The eligibility process was conducted in two separate stages:
1. The authors (E.V.-G. and B.E.E.) independently screened titles and abstracts of all nonduplicated papers
and excluded those with exclusion criteria. A definitive list was established. Discrepancies were
resolved by consensus between the authors. When there was no consensus, a third, senior author
(Y.B.-R.) acted as mediator. If any doubt about inclusion existed, the article proceeded to the
next stage.
2. Those articles that passed screening were downloaded (full text) and assessed for eligibility by
two authors (E.V.-G. and B.E.E.), independently. Again, discrepancies were resolved by consensus
between the authors, and if needed, two seniors author (Y.B.-R. and R.R.-V.) acted as arbitrators.
When required, the corresponding authors of screened studies were contacted to inquire about
study eligibility (n = 1).
Duplicates, nonintervention studies, non-English language, and studies without analysis of our
primary outcomes or main participants were eliminated. Articles included in the review are showed in
the PRISMA flow diagram (Figure 1).
2.3.2. Data Extraction
Data extraction was independently performed by two researchers (E.V.-G. and Y.B.-R.);
discrepancies were resolved by agreement between the two authors. The following data were extracted:
1. Publication details: year of publication and country where the study was conducted.
2. Study participants’ details: sample and age range.
3. Design of the study.
4. Intervention characteristic: duration and frequency of the intervention period.
5. Outcome: main outcome, secondary outcomes, and assessment test.
6. Main study results.
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Figure 1. PRISMA flow diagram of included studies on Mind–Body Therapies for the improvement 
of attention-deficit/hyperactivity disorder symptoms in children and adolescents. 
2.4. Study Quality Assessment 
Study quality was evaluated using the quality assessment tools from the Risk Assessment 
Workgroup of the Department of Health and Human Services from the U.S. National Institute of 
Health [19]. We assessed quality by two different tools: (1) quality assessment of controlled 
intervention studies (i.e., randomized controlled trials (RCTs) and clinical trials studies), and (2) 
quality assessment tool for before–after (pre–post) studies with no control group. These instruments 
were created to evaluate the internal validity of a trial, the extent to which the reported effects can 
strictly be attributed to the intervention applied, and the potential flaws in methodology or 
implementation. Each tool contains specific questions to assess bias, confounders, power, and 
strength of association between intervention and outcomes. The answer to each question could be 
“yes,” “no,” “cannot determine,” “not reported,” or “not applicable”. A numeric scoring system was 
not used. The evaluator had to consider the potential risk for bias in the study design whenever a 
“no” was selected. Overall quality ratings were scored as “good” (low risk of bias, valid results), 
“fair” (some risk of bias, does not invalidate results), or “poor” (significant risk for bias, may 
invalidate results). If a study had a “fatal flaw” then risk of bias was significant and the study was of 
poor quality. Examples of fatal flaws in RCTs include high dropout rates, high differential dropout 
rates, intention to treat analysis, or other inappropriate statistical analysis. All studies were 
independently screened by one author (Y.B.-R.), and three additional reviewers (E.V.-G., B.E.E., 
R.R.-V.) tested a 50% sample (n = 6) to double check for accuracy. 
Figure 1. PRIS A flow diagram of included studies on Mind–Body Therapies for the improvem nt of
attention-deficit/hyperactivity disorder symptoms in children and adolescents.
2.4. Study Quality Assessment
Study quality was evaluated using the quality assessment tools from the Risk Assessment
Workgroup of the Department of Health and Human Services from the U.S. National Institute of
Health [19]. We assessed quality by two different tools: (1) quality assessment of controlled intervention
studies (i.e., randomized controlled trials (RCTs) and clinical trials studies), and (2) quality assessment
tool for before–after (pre–post) studies with no control group. These instruments were created to
evaluate the internal validity of a trial, the extent to which the reported effects can strictly be attributed
to the intervention applied, and the potential flaws in methodology or implementation. Each tool
contains specific questions to assess bias, confounders, power, and strength of association between
intervention and outcomes. The answer to each question could be “yes,” “no,” “cannot determine,”
“not reported,” or “not applicable”. A numeric scoring system was not used. The evaluator had to
consider the potential risk for bias in the study design whenever a “no” was selected. Overall quality
ratings were scored as “good” (low risk of bias, valid results), “fair” (some risk of bias, does not
invalidate results), or “poor” (significant risk for bias, may invalidate results). If a study had a
“fatal flaw” then risk of bias was significant and the study was of poor quality. Examples of fatal flaws
in RCTs include high dropout rates, high differential dropout rates, intention to treat analysis, or other
inappropriate statistical analysis. All studies were independently screened by one author (Y.B.-R.),
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and three additional reviewers (E.V.-G., B.E.E., R.R.-V.) tested a 50% sample (n = 6) to double check
for accuracy.
3. Results
3.1. Study Selection
In the first stage of the search strategy, a total of (n = 506) articles were identified. In the second
stage, following the removal of duplicates (n = 157), a total of (n = 349) articles were screened by
title/abstract. Then, 316 potentially relevant articles were excluded with reasons (details summarized
in Figure 1). In the third stage, full-text articles were reviewed in depth and (n = 21) studies were
excluded with reasons (details summarized in Figure 1). Finally, only (n = 12) studies based on MBT
interventions met the inclusion and exclusion criteria and were included in the final analysis.
3.2. Characteristics of the Included Studies
The characteristics of the included studies are presented in Table 1. The included studies
were conducted in different continents, such as “the Americas” [20,21], Europe [22,23], Asia [24–30],
and Australia [31]. All analyzed studies targeted children and adolescents (ranged from 5 to 18 years
old). Only one study [20] also included adults, but results from adolescents and adults were displayed
separately. Moreover, most of the studies (11/12) [20–25,27–31] included parental participation,
supporting children to perform the program at home or being involved in the intervention. The number
of participants varied across the intervention studies, ranging from eight participants [20] to 100 [28].
Furthermore, the range of parent participation also varied from 11 [29] to 79 [25] families. Regarding the
study design, there were five RCT studies [25,27,28,30,31] and a clinical trial [24].
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Table 1. Characteristics of interventions of mind–body therapies for the improvement of ADHD symptoms (n = 12).
Author, Year
and Country
Sample and
Age
Intervention
Design
Type of
Intervention
Duration and
(Frequency) Outcomes and Tests Main Results Quality
#
[24] Taiwan 49 (8–12 yr) Non-randomizedcontrolled trial
Yoga exercise
group
versus control
group (negative)
8 weeks (twice per
week, 40 min per
session)
Primary outcomes: Selective and sustained attention
through Visual Pursuit Tests, and selective attention by
the Determination test. In both tests, the attention
outcomes were evaluated through the accuracy rate and
reaction time (RT).
After the intervention, significant improvements in
accuracy rate and reaction time of the two tests were
observed the yoga exercise group compared with the
control group. In the visual pursuit test, the exercise group
reported an increased accuracy rate after the yoga
intervention (t23 = −2.12, p = 0.045, d = −0.69), and a faster
RT at the post-test than the control group (t47 = −4.18,
p < 0.001, d = −1.20). For determination test, the yoga
exercise group reported an increased response accuracy (t23
= 5.78, p < 0.001, d = 1.22) and a faster RT at the post-test
than the control group (t47 = −4.26, p < 0.001, d = 1.25)
poor
[25] Israel 57 (6–15 yr) Non-randomizedcontrolled trial
Mindfulness
Training versus
non-violent
resistance parent
training
1 day (90 min
mindfulness skills
protocol)
Primary outcomes: Child externalizing symptoms were
evaluated through the Child Behavior Checklist
questionnaires and an intake session for a clinical
professional pchycologist
After intervention, parents in treatment conditions reported
a significant reduction in child externalizing symptoms on
the CBCL externalizing scale (ß = −4.73 (1.56), t = −3.04,
p = 0.002); change over time represented 51% of the
within-person variance.
fair
[26] India 9 (5–16 yr) Non-randomizedcontrolled trial
Yoga exercise
group
In-patient stay in
psychiatry unit. (1 h
session with at least
six sessions)
Primary outcomes: ADHD symptoms through ADHD
rating scale-IV (ADHD-RS), Conners’ abbreviated rating
scale (CARS) and clinical global impression (CGI) severity,
were evaluated at the beginning of study, at discharge,
and subsequently at the end of 1st, 2nd, and 3rd month by
a research associate not involved in yoga instruction.
A reduction in scores from baseline to discharge in all the
scales was observed (p = 0.014 on CARS and p = 0.021 on
ADHD-RS and 0.004 on CGI). There was no significant
reduction in the scores later on.
poor
[21] Canada 18 (13–18 yr) Non-randomizedcontrolled trial
Mindfulness-based
cognitive therapy
(MBCT)
8 weeks (1.5 h
session each week)
Primary outcomes: Screen of ADHD symptoms
(inattention, hyperactivity/impulsivity, learning problems,
aggression, oppositionality, and relationships with others)
were analyzed by self-report (Conners 3-SR) scales.
Secondary outcomes: Revised Child Anxiety and
Depression Scale—Youth (RCADS) at four time points (1
pre and 3 post)
Reductions in the adolescents’ inattention (near significant
p = 0.07; d = 0.62), conduct problems (p < 0.05; d = 0.70),
and peer relations problems (p < 0.05) after the MBCT
intervention, according to parental report.
poor
[31] Australia 18 (8–13 yr) Randomizedcrossover design
Yoga versus
control group
(positive)
20 weeks (1 h
program)
Primary outcomes: Screen of ADHD symptoms
(inattention, hyperactivity/impulsivity, learning problems,
aggression, oppositionality, and relationships with others)
were analyzed by the Conners’ Parent and Teacher Rating
Scales. Attention and impulsivity were evaluated by the
Test of Variables of Attention (TOVA), and hyperactivity
was assesed by the Motion Logger Actigraph.
Regarding the Conners’ Parent and Teacher Rating scales,
there were significant
effects for the yoga group on five subscales of the CPRS:
Oppositional (p = 0.003, Cohen’s d = 0.77); Global Index
Emotional Lability (p = 0.001, Cohen’s d = 0.79); Global
IndexTotal (p = 0.001; Cohen’s d = 0.73);
Global Index Restless/Impulsive (p = 0.008, Cohen’s d =
0.73) and ADHD Index (p = 0.019, Cohen’s d = 0.29). Days
of home practice were positively associated with three
factors—TOVA Response Time Variability (r = 0.628, p =
0.038), TOVA/ADHD score (r = 0.648, p = 0.05), and
CTRS–R:L Global Emotional Lability (r = −0.628, p = 0.05)
poor
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Table 1. Cont.
[27] Iran 30 (13–15 yr) Randomizedcrossover design
Mindfulness
treatment group
versus waitlist
control group
(negative)
8 weeks (1
session/1.5-h)
Primary outcomes: Executive functioning was assesed by
the following test: Continuous performance test (CPT for
continuous attention dysfunction and response inhibition,
Digit Span (Forward and Backward) subtest and
Letter–Number
Secondary outcomes: Sequencing subtest of working
memory index of Wechsler Intelligence Scale for
Children—Fourth Edition (WISC-IV), Stroop
Word–Colour Interference Test for inhibition, and Tower
of London test.
For executive functions: Treatment group had a
significantly higher inhibition than the control group at
post-test (F(1, 27) = 7.58, p = 0.01, partial η2 = 0.22).
Planning of the treatment group was significantly different
than the control group (F(1, 27) = 4.88, p = 0.04; partial η2 =
0.15). For Emotion dysregulation, the treatment group had
lower emotion dysregulation (F(1, 27) = 6.41, p = 0.02,
partial η2 = 0.19), Nonacceptance of Emotion Responses
(F(1, 27) = 9.67, p = 0.004; partial η2 = 0.26), and Impulse
Control Difficulties (F(1,27) = 7.97, p = 0.009; partial η2 =
0.26), in comparison with the control group.
poor
[28] China 100 (5–7 yr) RandomizedControl Trial
Family-based
mindfulness
intervention
versus waitlist
control group
(negative)
6 weeks (8
sessions/child
program)
Primary outcomes: Inattention and
hyperactivity/impulsivity by SWAN scale, Internalizing
and externalizing problems by Child Behavior Checklist,
Attention by Child Behavior Checklist, ADHD Symptoms
by The ADHD Rating Scale [ARS] assesed at pre tests,
immediately after the 8 week training, and at 8 week
follow-up.
Families from intervention group had greater
improvements in children’s ADHD symptoms, with
medium effect sizes of −0.60 for inattention and −0.59 for
hyperactivit compared with the wait-list control group.
with the wait-list control group
poor
[22]
Netherlands 22 (8–12 yr)
Non-randomized
controlled trial
Mindfulness
School-based
program and
within-group
waitlist (negative)
8 weeks (1.5 h
sessions)
Primary outcomes: Disruptive behavior disorder
symptoms through Disruptive Behavior Disorder Rating
Scale [DBDRS].
From pre to post test, significant reduction of inattention (ES
= 0.80, large ES) and hyperactivity/impulsivity symptoms
of the child (ES = 0.56, medium ES) on the parent-rated
DBDRS, and a significant reduction of the parental
inattention and hyperactivity/impulsivity symptoms on the
ARS, with small effect sizes (ES = 0.36 and 0.48,
respectively). From pre to follow-up, again, inattention and
hyperactivity/impulsivity showed significant reductions
with small to large effect sizes in both parent (ES = 0.34/0.50,
respectively) and child (ES = 0.80/0.59, respectively).
poor
[20] EEUU 8 (mean age =15.6 (1.1) yr)
Non-randomized
controlled trial Mindfulness
8 week program
(once-per-week
evening sessions
lasting 2.5 h and
daily at-home
practice)
Primary outcomes:
ADHD symptoms by the SNAP-IV scale (adolescents).
Attentional conflict by Stroop task.
Attentional set-shifting and inhibition by the Trail Making
Test.
Attention through the Attention Network Test.
Working memory by the Digit Span.
Secondary outcomes:
Intelligence Scale–Revised or Wechsler Intelligence Scale.
Self-report of anxiety and depression was assessed via the
Child Depression Inventory and the Revised Children’s
Manifest Anxiety Scale (RCMAS) for adolescents.
Verbal IQ by Wechsler Intelligence Scale for
Children—Third Edition,
Regarding ADHD symptoms, significnatly reductions were
observed for inattentive and combined (p < 0.001).
For cognitive measures, a significant decrease was observed
in Attention Network Test conflict, Trails A, and Trails B
(p < 0.001), and a significant increase was observed in
Stroop color word.
Slight changes were observed for depression and anxiety.
poor
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[29] China 11 (8–12 yr) Non-randomizedcontrolled trial Mindfulness
8 weeks (90 min
group sessions)
Primary outcomes: Childrens’ attention and related
problems by The Conners’ Continuous Performance Test
3rd Edition (CPT 3) and the Test of Everyday Attention
for Children (TEA-Ch) for selective attention, sustained
attention, and attention control/switching.
Secondary outcomes:
Parents’ perception of disruptive behavior by the Eyberg
Child Behavior Inventory (ECBI)
Positive results with large effect sizes only occurred on the
objective attention tests: time per target (p = 0.0003;
ES = 1.53, large ES), the attention score (p = 0.001; ES = 1.35,
large ES) of the Sky Search test, and Map Mission test
(p = 0.0001; ES = 1.27, large ES) of TEA-Ch. For omissions,
T score improved from 87.9 (6.9) to 58.4 (16.9), p = 0.0003;
ES = 2.29, large ES) in the computerized CPT 3 test, which
indicates better attention. No statistically significant
changes were seen in other measures of the Test of
Everyday Attention for Children (TEA-Ch).
poor
[23]
Netherlands 10 (11 to 15 yr)
Non-randomized
controlled trial Mindfulness
8 weeks (1.5 h
sessions.)
Primary outcomes:
Attention and behavioral problems
Youth Self Report (YSR) and the Child Behavior Checklist
(CBCL),
Secondary outcomes:
Executive Function
The Behavior Rating Inventory of Executive Function
(BRIEF) Mindful awareness.
Mindful Attention and Awareness
Scale (MAAS)
After mindfulness training, significant reduction in
attention problems was reported after training by fathers
for attention, (95% CI, −5.35 to 0.046, p = 0.09 and in
internalizing problems (95% CI, −8.09 to 0.09, p = 0.05).
Metacognition and behavioral regulation significantly
improved after training, reported by tutors (95% CI, −18.94
to 1.39, p = 0.08), reported bu fathers (95% CI, −12.97 to 0.40,
p = 0.06)
poor
[30] Iran 56 (7–12 yr) RandomizedControl Trial
Mindful Parenting
Training versus
control group
(positive)
8 weeks (1
session/90 min)
Primary outcomes:
Attention deficit, hyperactivity
Disorder, attention deficit hyperactivity disorder.
Secondary outcomes:
Swanson, Nolan, and Pelham Parent and
Teacher Rating Scale (SNAP-IV)
There were signifficant differences between experimental
and control group after the intervention program (postest)
in all measured variables: Attention deficit (p = 0.001),
hyperactivity (p = 0.04), and attention deficit hyperactivity
disorder (p = 0.04)
Poor
Included: strongly related to the primary outcome and study population (children and adolescents), ANT: Attention Network Test, ADHDRS: Rating Scale of ADHD, CBCL: Child
Behavior Checklist, CPRS: Comprehensive Psychopathological Rating Scale, TOVA: Test of Variables of Attention, MAAS: Mindful Attention and Awareness Scale, AGN: Affective
Go/No-Go test, MAAS: Mindful Attention and Awareness Scale, AGN: Affective Go/No-Go test. # NIH Quality Assessment Tools for (1) Quality Assessment of Controlled Intervention
Studies (i.e., RCT and clinical studies); and (2) Quality Assessment Tool for Before–After (Pre–Post) Studies with No Control Group.
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3.3. Analysis of the MBT Intervention and its Effects on ADHD Outcomes
3.3.1. MBT Interventions
All interventions consisted of MBTs, including nine studies developing mindfulness
treatment [20–23,25,27–30] and three studies that conducted yoga [24,26,31]. Five studies [20,24,26,29,31]
declared that interventions were guided by a certified instructor in mindfulness or yoga. For instance,
in the study of [20] instruction was carried out by an experienced mindfulness instructor. In addition,
six studies received the interventions in a homework format, such as an audio CD-ROM and
workbooks that guided meditations to support home practice [21], an audio CD-ROM with mindfulness
exercises to practice at home [22,23,29,30], and CD-ROMs containing guided sitting meditations [20].
The majority were school-based programs (7/12), whereas one study was carried out in a yoga
studio [24]. Regarding the intervention period, most of them lasted eight weeks (8/12), finding that the
intervention with the greatest duration lasted 20 weeks [31], whereas the shortest duration was one day
(including a 90 min session of mindfulness skills protocol) [25]. Concerning frequency, most studies
included at least one session per week (9/12 studies), whereas the duration of the sessions varied across
studies, in a range between 40 and 150 min. Finally, four studies [22,24,27,28] included a negative
control group (three of these with a wait list control group), and two studies a positive control group,
including cooperative activities [32] and pharmacotherapy with risperidone or ritalin [30].
3.3.2. Effects of MBT Interventions on ADHD
Regarding the effect of the interventions on the main ADHD symptoms in children and
adolescents, in general, there were significant positive results in eleven out of twelve of the studies
(91.6%) [20–24,26–31], even though in the study of [25] there were no differences on externalizing
symptoms in children after the intervention. With respect to evaluating the main ADHD symptoms,
we observed significant improvement across studies on primary outcomes, such as accuracy rate and
reaction time [24], hyperactivity and impulsivity [31], as well as on inattention [28].
Secondary outcomes, such as anxiety, shyness, social problems, perfectionism, and impulsivity [31],
planning, inhibition, and self-reported emotion dysregulation [27], and depressive symptoms [20] were
also significantly improved after MBT interventions. Finally, several specific instruments to measure
ADHD symptoms were used (e.g., checklist, questionnaires, visual test, scales, etc.).
3.4. Methodological Quality of the Included Studies
In summary, eleven studies were rated “poor”, and only one was rated as “fair” [25]
(see Supplementary Tables S2 and S3).
3.4.1. Quality Assessment of Controlled Intervention Studies
We assessed six studies with this tool (i.e., five RCT studies and a clinical trial). Five [24,27,28,30,31]
of the six identified controlled studies included a “fatal flaw”, resulting in a “poor” rating.
The randomization process was described in all six controlled studies [24,25,27,28,30,31], and all
of them correctly described the randomization sequence. Only one RCT study [25] conducted
independent recruitment of participants and blinding. All the controlled intervention studies had
similar groups at baseline on important characteristics that could affect the outcome of the study.
The overall dropout rates from all the studies at endpoint were lower than 20%, as well as the
differential dropout rates between intervention and control group, which were over 15%. Adherence to
the intervention program was high in all groups, whereas the application of other interventions was
not described in any cases. Furthermore, none of the six controlled intervention studies reported an
appropriately sized sample necessary for detecting effects with 80% power. Finally, in all studies,
all randomized participants were analyzed in the group to which they were originally assigned
(per protocol analysis).
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3.4.2. Quality Assessment for Before–After Studies (Pre–Post) Studies with No Control Group
We assessed six studies with this tool (i.e., non-random studies without a control group). The six
studies [20–23,26,29] included at least one “fatal flaw”, resulting in a “poor” rating. All studies included
the study question and clearly stated the objective, as well as clearly describing eligibility/selection
criteria for the study participants. In the six studies, participants were representative of those who were
eligible for the intervention, but they did not include a sample size appropriate to provide assurance in
their findings. The outcome assessments were detailed, clearly described, valid, reliable, and assessed
consistently across all study participants; however, in none of the studies were the people who assessed
the outcomes blinded to the participants’ interventions. In all of the studies, the loss to follow-up after
baseline was lower than 20%. Regarding statistical methods, only three studies [20,23,29] examined
changes in outcome measures between pre–post intervention, providing the p values. In addition,
in three studies [20,21,26], statistical analysis used the individual-level data to determine effects at the
group level. Finally, in three studies [21,23,26], the outcome was measured at multiple times along the
MBT intervention. Due to heterogeneity in the measurement of mind–body therapies outcomes (i.e.,
inattention, hyperactivity, or impulsivity, and related skills), type intervention (i.e., yoga, meditation,
mindfulness, relaxation, or zen therapies or programs), and on types of comparators (i.e., no treatment
as negative control group or traditional intervention as positive control group), doing a meta-analysis
was not possible (see Table 1).
4. Discussion
The main findings of this SR were that a significant positive result was found in eleven out
of twelve included studies regarding the effect of the MBTs on ADHD symptoms in children and
adolescents. In addition, in relation to the quality of the studies, eleven studies were rated “poor” and
one was rated as “fair”. A more detailed description of the types of intervention used and the effects
produced on the main ADHD symptoms and other related factors are described below.
ADHD persists into adulthood in up to 80% of individuals diagnosed as children [33], so prevention
and mitigation of ADHD symptoms are important from an early age. Stimulant medication is the most
usual first-line treatment for ADHD for people of all ages. RCTs have proven the effectiveness of stimulants
in reducing core symptoms of ADHD in youth [18]. However, a high proportion of young people in these
trials were considered nonresponders. Additionally, although stimulant medication is a key component
of ADHD treatment, it is necessary to explore the multidimensional effect of other complementary
interventions for young people with ADHD, such as nonpharmacological programs, i.e., school-based
intervention strategies, psychotherapy, and cognitive–behavioral interventions [34]. Consequently,
the positive effects of physical exercise have been described on the same catecholaminergic system
targeted by stimulant medications for ADHD [35,36]. Additionally, pharmacotherapy has been related
to side effects such as poor tolerance, no response to treatment, and even dependence [10]. Thus,
physical exercise could be considered a helper to decrease behavioral problems that influence the
learning and academic processes in children with ADHD [10].
As a form of exercise, MBTs, including tai chi, meditation, mindfulness, and yoga, have been put
in the crosshairs of the scientific community to analyze in depth the effectiveness of these widely used
practices. Accordingly, the National Center for Complementary and Alternative Medicine designates
MBTs as a top research priority [6]. According to Morgan et al., MBTs such as tai chi or yoga are
multidimensional behavioral therapies that integrate several aspects of physical exercise, such as light
to moderate aerobic physical activity, deep breathing, balance, and meditation to encourage stress
reduction and relaxation, which could potentially impact ADHD symptoms. Moreover, it has been
demonstrated that meditation is a more integrative program for stress reduction, regulating emotional,
and affective responses to stress. A recent review [37] with 12 preliminary studies of yoga in schools
for children, established that yoga interventions applied positive effects on factors such as emotional
balance, attentional control, cognitive efficiency, anxiety, negative thought patterns, emotional and
physical arousal, reactivity, and negative behavior. Additional research in children also showed
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the positive effects of school-based yoga programs on several aspects of mental health, such as
concentration, attention, anxiety, stress, mood, resilience, emotional arousal, self-esteem, and coping
frequency [38]. However, to date few studies were carried out with MBTs, such as yoga or mindfulness,
in children and adolescents with ADHD.
In the current SR, we included twelve studies based on MBTs in children and adolescents with
diagnoses of ADHD. Nine developed mindfulness treatments [20–23,25,27–30], three conducted yoga
programs [24,26,31], and none of these included others such as Zen, tai chi, or specific meditation
therapies. Most of the included studies (11/12) displayed significant positive results on ADHD
symptoms, where only the study of Gershy et al. [25] did not show significant positive results regarding
ADHD symptoms after the intervention. A possible explanation for this lack of effect on ADHD
symptoms could be that the intervention period was only one day, including a session of 90 min
of mindfulness skills protocol. In this sense, evidence-based interventions often involved 7 to 12
weekly sessions, demonstrating improved child behavior and parent satisfaction [39,40], in addition
three to four weeks on stable medication is the minimum length of treatment efficacy in subjects
with ADHD [41]. Accordingly, the present SR displayed that most of the included studies (8/12)
carried out an intervention for at least eight weeks, including a study with a duration of 20 weeks [31].
So, future intervention studies should include intensive training lasting at least seven to eight weeks
of intervention. For example, in two case studies of children with ADHD, a significant decrease in
compliance of the child was described after an intensive mindfulness program including 12 sessions
(twice weekly) [42]. Future research must establish the optimal frequency, duration, and intensity of
intervention programs to lead to effective interventions.
In the study of [25], no differences in child externalizing symptoms were found, which decreased
significantly in both groups after intervention. However, mothers’ negative feelings, escalating behaviors,
and capacity for emotional regulation improved significantly at the end of the intervention. Moreover,
fathers in the mindfulness condition reported greater improvement in the capacity for emotional
regulation, reduced negative feelings, and reduced parental submission compared with fathers in
the parent training condition. Thus, it is possible that interventions focused only on youth may be
more effective than those that include both young people and parents. Contrary to this hypothesis,
effective behavioral therapies include parent and youth training, with classroom management,
peer interventions, or combinations of these interventions [43]. It seems that parent training improves
their understanding of ADHD, behavioral problems, and child development, helping them to use
strategies such as praise and rewards for targeted behaviors. Additionally, disruptive child behaviors
are decreased. Thereby, MBTs involving both parents and youths seem to have a positive influence
on family relationships, further improving ADHD symptoms in children and adolescents, as shown
by three of the studies included in the present review [21,22,28]. Additionally, it is important
to take into account that ADHD is a neurodevelopmental disorder, which could remit and even
transform some symptoms and deficits into adaptive behaviors or even lead a negative trajectory.
The patient’s compliance and feeling regarding the medical therapy [44–46] and an optimal medical
and multicomponent treatment is the key to ensure positive effects.
Concerning study quality, even though we included four RCT studies and a clinical trial, most of
the studies (11/12) were rated as “poor” quality, while only the study of [25] was rated as “fair” quality.
Again, we hypothesized that the reason for the difference between studies could be the duration of the
intervention (i.e., one day of a 90 min session of mindfulness skills protocol), since the short duration
(one day) in the intervention could avoid several “fatal flaws” in the design or development of the
study (e.g., blinding of participants or providers to the treatment group assignments, etc.).
Another important criteria that could influence the quality assessment differences between the
study of Gershy et al. and the rest of the controlled intervention studies could be the dropout rate,
since previous literature has shown that there is usually an important prevalence of dropouts in exercise
interventions [47]. However, in the current SR, all of controlled intervention studies met both criteria
for not having a “fatal flaw”, i.e., overall dropout rate from the study at endpoint (20% or lower) and
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differential dropout rate (between treatment groups) at endpoint (15% or lower). In this respect, it seems
that lower dropout was observed in sports interventions compared with structured aerobic exercise or
yoga (p = 0.049), so in order to increase participation, and therefore health benefits, MBT interventions
must offer a multidisciplinary approach for children and adolescents with ADHD [47].
In addition to the satisfactory dropout rate across the studies, most of the controlled intervention
studies had a high adherence to the intervention programmes (4/6). However, regarding before–after
studies with no control group, only the studies of Zylowska et al. [20] and Zhang et al. [29] reported a high
rate of adherence, with 78% and 91%, respectively. Regarding adherence correlates, family problems
was the main reason for nonadherence among children to yoga practice at home post-discharge [26].
The high percentage of adherence, as well as the low dropout rate could be due to different reasons.
First, we hypothesized that there was high satisfaction among the participants who enjoyed MBTs.
For instance, Zylowska and colleagues (2008) conducted an open trial of a mindfulness training
program where high satisfaction ratings from adolescents were reported. Another possible reason that
could explain these two positive aspects in the quality of interventions, i.e., dropout and adherence
rates, could be that the sample size was small in all of the studies (12/12), allowing greater control and
individual monitoring of the participants. However, an insufficiently large sample size was one of the
most usual “fatal flaws” across the studies.
In the controlled intervention studies, none reported a sufficiently large sample size to be able
to detect a difference in the main outcome between groups with at least 80% power, as well as in
the before–after studies with no control group (6/6), in which the sample size was not sufficiently
large to provide confidence in the findings. Thus, small sample sizes in these studies precludes the
generalizability of the findings, resulting in a poor quality of the study. Therefore, although most
studies reported positive benefits on ADHD symptoms of children and adolescents after completing
MBTs, their quality was rated mostly as poor, so future intervention studies should include larger
samples as well as randomization and control groups, in order to clarify these findings.
Results of our review study must be viewed in the light of methodological limitations. Overall,
the “poor” and “fair” quality ratings for the majority of studies makes it difficult to conclude with
consistency regarding future intervention strategies, mainly because risk of bias in the study design
critically decreases the confidence in the rationality of the results. Albeit, some aspects must be
considered in cases of exercise intervention studies. First, it is possible to find gaps when assessing
the quality of the studies using the NIH tools, since these were designed principally for clinical trial
studies. For example, the blinding element could be considered inapplicable because it is practically
impossible to blind participants who receive MBTs such as yoga or mindfulness. Second, some studies
did not specify the intensity/frequency of the intervention, as well as quality criteria such as adherence
or in-depth details of the statistical methods. Third, most studies did not report if the participants were
involved or stopped some medical or psychological treatment for their ADHD symptoms, or if they
performed some additional physical activity, sport, or exercise. Neither were the participants analyzed
according to the subtype of ADHD diagnosis. Fourth, the quality of included studies ranked mainly as
poor; however, we did not exclude any because of the small number of articles selected. As a strength,
a rigorous and strict review process was performed for selecting the studies and extracting the data.
Additionally, two valid instruments to evaluate the studies quality were used. Finally, we have not
included in this manuscript an SR with a quantitative analysis (meta-analysis) due to the considerable
conceptual heterogeneity in the studies (systematic differences in study design, patient populations,
interventions or co-interventions, clinical heterogeneity, including duration of the study, the dose of
the intervention, and the evaluation of the results). In addition, we observed that the studies were
systematically different from each other, so the quantitative synthesis would not be generalizable and
applicable to clinical practice. In this context, we recognize and explain the heterogeneity in inclusion
studies, particularly from a qualitative perspective, which is a general sense of what all studies say,
and is absolutely crucial, especially when analyzing controlled intervention and before–after studies.
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5. Conclusions
Most of the intervention studies conducting MBTs in children and adolescents with ADHD
indicated positive results for improving ADHD symptoms. The majority of them were eight
week school-based programs based on mindfulness treatment, guided by a certified instructor,
with a frequency of one session per week, and with duration in a range between 40 and 150 min.
However, the studies were identified as being of poor quality. Thus, further studies should be more
rigorous to improve the consistency and generalizability of their findings. They must include the
use of representative samples with greater statistical power and randomized controlled trial designs.
Finally, further research should include behavioral interventions such as MBTs in conjunction with
pharmacological treatment.
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